Global Corticosteroid Medication Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Corticosteroid Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
By Company
- Sumitomo
- Pfizer
- Novartis
- Merck
- Sanofi
- Johnson & Johnson
- GSK
- AstraZeneca
- Cipla
- LEO Pharma
- Abbott Laboratories
- Bayer
- Tianjin Tianyao Pharmaceuticals Co., Ltd.
- Zhejiang Xianju Pharmaceutical Co.,Ltd
- Shandong Xinhua Pharmaceutical Company Limited
- Yangzi River Pharmaceutical Group
- Tablets
- Capsules
- Eye Drops
- Lotions, Creams, Ointments, or Gels
- Nasal or Mouth Sprays
- Injections
- Hospital
- Clinic
- Pharmacy
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 CORTICOSTEROID MEDICATION MARKET OVERVIEW
1.1 Product Overview and Scope of Corticosteroid Medication
1.2 Corticosteroid Medication Segment by Type
1.2.1 Global Corticosteroid Medication Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Eye Drops
1.2.5 Lotions, Creams, Ointments, or Gels
1.2.6 Nasal or Mouth Sprays
1.2.7 Injections
1.3 Corticosteroid Medication Segment by Application
1.3.1 Global Corticosteroid Medication Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Corticosteroid Medication Market Size Estimates and Forecasts
1.4.1 Global Corticosteroid Medication Revenue 2018-2029
1.4.2 Global Corticosteroid Medication Sales 2018-2029
1.4.3 Global Corticosteroid Medication Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CORTICOSTEROID MEDICATION MARKET COMPETITION BY MANUFACTURERS
2.1 Global Corticosteroid Medication Sales Market Share by Manufacturers (2018-2023)
2.2 Global Corticosteroid Medication Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Corticosteroid Medication Average Price by Manufacturers (2018-2023)
2.4 Global Corticosteroid Medication Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Corticosteroid Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Corticosteroid Medication, Product Type & Application
2.7 Corticosteroid Medication Market Competitive Situation and Trends
2.7.1 Corticosteroid Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Corticosteroid Medication Players Market Share by Revenue
2.7.3 Global Corticosteroid Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CORTICOSTEROID MEDICATION RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Corticosteroid Medication Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Corticosteroid Medication Global Corticosteroid Medication Sales by Region: 2018-2029
3.2.1 Global Corticosteroid Medication Sales by Region: 2018-2023
3.2.2 Global Corticosteroid Medication Sales by Region: 2024-2029
3.3 Global Corticosteroid Medication Global Corticosteroid Medication Revenue by Region: 2018-2029
3.3.1 Global Corticosteroid Medication Revenue by Region: 2018-2023
3.3.2 Global Corticosteroid Medication Revenue by Region: 2024-2029
3.4 North America Corticosteroid Medication Market Facts & Figures by Country
3.4.1 North America Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Corticosteroid Medication Sales by Country (2018-2029)
3.4.3 North America Corticosteroid Medication Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Corticosteroid Medication Market Facts & Figures by Country
3.5.1 Europe Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Corticosteroid Medication Sales by Country (2018-2029)
3.5.3 Europe Corticosteroid Medication Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Corticosteroid Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Corticosteroid Medication Sales by Country (2018-2029)
3.6.3 Asia Pacific Corticosteroid Medication Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Corticosteroid Medication Market Facts & Figures by Country
3.7.1 Latin America Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Corticosteroid Medication Sales by Country (2018-2029)
3.7.3 Latin America Corticosteroid Medication Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Corticosteroid Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Corticosteroid Medication Sales by Country (2018-2029)
3.8.3 Middle East and Africa Corticosteroid Medication Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Corticosteroid Medication Sales by Type (2018-2029)
4.1.1 Global Corticosteroid Medication Sales by Type (2018-2023)
4.1.2 Global Corticosteroid Medication Sales by Type (2024-2029)
4.1.3 Global Corticosteroid Medication Sales Market Share by Type (2018-2029)
4.2 Global Corticosteroid Medication Revenue by Type (2018-2029)
4.2.1 Global Corticosteroid Medication Revenue by Type (2018-2023)
4.2.2 Global Corticosteroid Medication Revenue by Type (2024-2029)
4.2.3 Global Corticosteroid Medication Revenue Market Share by Type (2018-2029)
4.3 Global Corticosteroid Medication Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Corticosteroid Medication Sales by Application (2018-2029)
5.1.1 Global Corticosteroid Medication Sales by Application (2018-2023)
5.1.2 Global Corticosteroid Medication Sales by Application (2024-2029)
5.1.3 Global Corticosteroid Medication Sales Market Share by Application (2018-2029)
5.2 Global Corticosteroid Medication Revenue by Application (2018-2029)
5.2.1 Global Corticosteroid Medication Revenue by Application (2018-2023)
5.2.2 Global Corticosteroid Medication Revenue by Application (2024-2029)
5.2.3 Global Corticosteroid Medication Revenue Market Share by Application (2018-2029)
5.3 Global Corticosteroid Medication Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sumitomo Corticosteroid Medication Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Corticosteroid Medication Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Corticosteroid Medication Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Corticosteroid Medication Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Corticosteroid Medication Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Corticosteroid Medication Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Corticosteroid Medication Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Corticosteroid Medication Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Corticosteroid Medication Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 LEO Pharma
6.10.1 LEO Pharma Corporation Information
6.10.2 LEO Pharma Description and Business Overview
6.10.3 LEO Pharma Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.10.4 LEO Pharma Corticosteroid Medication Product Portfolio
6.10.5 LEO Pharma Recent Developments/Updates
6.11 Abbott Laboratories
6.11.1 Abbott Laboratories Corporation Information
6.11.2 Abbott Laboratories Corticosteroid Medication Description and Business Overview
6.11.3 Abbott Laboratories Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abbott Laboratories Corticosteroid Medication Product Portfolio
6.11.5 Abbott Laboratories Recent Developments/Updates
6.12 Bayer
6.12.1 Bayer Corporation Information
6.12.2 Bayer Corticosteroid Medication Description and Business Overview
6.12.3 Bayer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bayer Corticosteroid Medication Product Portfolio
6.12.5 Bayer Recent Developments/Updates
6.13 Tianjin Tianyao Pharmaceuticals Co., Ltd.
6.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information
6.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Description and Business Overview
6.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolio
6.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.14 Zhejiang Xianju Pharmaceutical Co.,Ltd
6.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
6.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Description and Business Overview
6.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolio
6.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
6.15 Shandong Xinhua Pharmaceutical Company Limited
6.15.1 Shandong Xinhua Pharmaceutical Company Limited Corporation Information
6.15.2 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Description and Business Overview
6.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolio
6.15.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.16 Yangzi River Pharmaceutical Group
6.16.1 Yangzi River Pharmaceutical Group Corporation Information
6.16.2 Yangzi River Pharmaceutical Group Corticosteroid Medication Description and Business Overview
6.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolio
6.16.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Corticosteroid Medication Industry Chain Analysis
7.2 Corticosteroid Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Corticosteroid Medication Production Mode & Process
7.4 Corticosteroid Medication Sales and Marketing
7.4.1 Corticosteroid Medication Sales Channels
7.4.2 Corticosteroid Medication Distributors
7.5 Corticosteroid Medication Customers
8 CORTICOSTEROID MEDICATION MARKET DYNAMICS
8.1 Corticosteroid Medication Industry Trends
8.2 Corticosteroid Medication Market Drivers
8.3 Corticosteroid Medication Market Challenges
8.4 Corticosteroid Medication Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Corticosteroid Medication
1.2 Corticosteroid Medication Segment by Type
1.2.1 Global Corticosteroid Medication Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Eye Drops
1.2.5 Lotions, Creams, Ointments, or Gels
1.2.6 Nasal or Mouth Sprays
1.2.7 Injections
1.3 Corticosteroid Medication Segment by Application
1.3.1 Global Corticosteroid Medication Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Corticosteroid Medication Market Size Estimates and Forecasts
1.4.1 Global Corticosteroid Medication Revenue 2018-2029
1.4.2 Global Corticosteroid Medication Sales 2018-2029
1.4.3 Global Corticosteroid Medication Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CORTICOSTEROID MEDICATION MARKET COMPETITION BY MANUFACTURERS
2.1 Global Corticosteroid Medication Sales Market Share by Manufacturers (2018-2023)
2.2 Global Corticosteroid Medication Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Corticosteroid Medication Average Price by Manufacturers (2018-2023)
2.4 Global Corticosteroid Medication Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Corticosteroid Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Corticosteroid Medication, Product Type & Application
2.7 Corticosteroid Medication Market Competitive Situation and Trends
2.7.1 Corticosteroid Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Corticosteroid Medication Players Market Share by Revenue
2.7.3 Global Corticosteroid Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CORTICOSTEROID MEDICATION RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Corticosteroid Medication Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Corticosteroid Medication Global Corticosteroid Medication Sales by Region: 2018-2029
3.2.1 Global Corticosteroid Medication Sales by Region: 2018-2023
3.2.2 Global Corticosteroid Medication Sales by Region: 2024-2029
3.3 Global Corticosteroid Medication Global Corticosteroid Medication Revenue by Region: 2018-2029
3.3.1 Global Corticosteroid Medication Revenue by Region: 2018-2023
3.3.2 Global Corticosteroid Medication Revenue by Region: 2024-2029
3.4 North America Corticosteroid Medication Market Facts & Figures by Country
3.4.1 North America Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Corticosteroid Medication Sales by Country (2018-2029)
3.4.3 North America Corticosteroid Medication Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Corticosteroid Medication Market Facts & Figures by Country
3.5.1 Europe Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Corticosteroid Medication Sales by Country (2018-2029)
3.5.3 Europe Corticosteroid Medication Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Corticosteroid Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Corticosteroid Medication Sales by Country (2018-2029)
3.6.3 Asia Pacific Corticosteroid Medication Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Corticosteroid Medication Market Facts & Figures by Country
3.7.1 Latin America Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Corticosteroid Medication Sales by Country (2018-2029)
3.7.3 Latin America Corticosteroid Medication Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Corticosteroid Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Corticosteroid Medication Sales by Country (2018-2029)
3.8.3 Middle East and Africa Corticosteroid Medication Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Corticosteroid Medication Sales by Type (2018-2029)
4.1.1 Global Corticosteroid Medication Sales by Type (2018-2023)
4.1.2 Global Corticosteroid Medication Sales by Type (2024-2029)
4.1.3 Global Corticosteroid Medication Sales Market Share by Type (2018-2029)
4.2 Global Corticosteroid Medication Revenue by Type (2018-2029)
4.2.1 Global Corticosteroid Medication Revenue by Type (2018-2023)
4.2.2 Global Corticosteroid Medication Revenue by Type (2024-2029)
4.2.3 Global Corticosteroid Medication Revenue Market Share by Type (2018-2029)
4.3 Global Corticosteroid Medication Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Corticosteroid Medication Sales by Application (2018-2029)
5.1.1 Global Corticosteroid Medication Sales by Application (2018-2023)
5.1.2 Global Corticosteroid Medication Sales by Application (2024-2029)
5.1.3 Global Corticosteroid Medication Sales Market Share by Application (2018-2029)
5.2 Global Corticosteroid Medication Revenue by Application (2018-2029)
5.2.1 Global Corticosteroid Medication Revenue by Application (2018-2023)
5.2.2 Global Corticosteroid Medication Revenue by Application (2024-2029)
5.2.3 Global Corticosteroid Medication Revenue Market Share by Application (2018-2029)
5.3 Global Corticosteroid Medication Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sumitomo Corticosteroid Medication Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Corticosteroid Medication Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Corticosteroid Medication Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Corticosteroid Medication Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Corticosteroid Medication Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Corticosteroid Medication Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Corticosteroid Medication Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Corticosteroid Medication Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Corticosteroid Medication Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 LEO Pharma
6.10.1 LEO Pharma Corporation Information
6.10.2 LEO Pharma Description and Business Overview
6.10.3 LEO Pharma Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.10.4 LEO Pharma Corticosteroid Medication Product Portfolio
6.10.5 LEO Pharma Recent Developments/Updates
6.11 Abbott Laboratories
6.11.1 Abbott Laboratories Corporation Information
6.11.2 Abbott Laboratories Corticosteroid Medication Description and Business Overview
6.11.3 Abbott Laboratories Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abbott Laboratories Corticosteroid Medication Product Portfolio
6.11.5 Abbott Laboratories Recent Developments/Updates
6.12 Bayer
6.12.1 Bayer Corporation Information
6.12.2 Bayer Corticosteroid Medication Description and Business Overview
6.12.3 Bayer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bayer Corticosteroid Medication Product Portfolio
6.12.5 Bayer Recent Developments/Updates
6.13 Tianjin Tianyao Pharmaceuticals Co., Ltd.
6.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information
6.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Description and Business Overview
6.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolio
6.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.14 Zhejiang Xianju Pharmaceutical Co.,Ltd
6.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
6.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Description and Business Overview
6.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolio
6.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
6.15 Shandong Xinhua Pharmaceutical Company Limited
6.15.1 Shandong Xinhua Pharmaceutical Company Limited Corporation Information
6.15.2 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Description and Business Overview
6.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolio
6.15.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.16 Yangzi River Pharmaceutical Group
6.16.1 Yangzi River Pharmaceutical Group Corporation Information
6.16.2 Yangzi River Pharmaceutical Group Corticosteroid Medication Description and Business Overview
6.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolio
6.16.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Corticosteroid Medication Industry Chain Analysis
7.2 Corticosteroid Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Corticosteroid Medication Production Mode & Process
7.4 Corticosteroid Medication Sales and Marketing
7.4.1 Corticosteroid Medication Sales Channels
7.4.2 Corticosteroid Medication Distributors
7.5 Corticosteroid Medication Customers
8 CORTICOSTEROID MEDICATION MARKET DYNAMICS
8.1 Corticosteroid Medication Industry Trends
8.2 Corticosteroid Medication Market Drivers
8.3 Corticosteroid Medication Market Challenges
8.4 Corticosteroid Medication Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Corticosteroid Medication Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Corticosteroid Medication Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Corticosteroid Medication Market Competitive Situation by Manufacturers in 2022
Table 4. Global Corticosteroid Medication Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Corticosteroid Medication Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Corticosteroid Medication Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Corticosteroid Medication Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Corticosteroid Medication Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Corticosteroid Medication, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Corticosteroid Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Corticosteroid Medication, Product Type & Application
Table 12. Global Key Manufacturers of Corticosteroid Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Corticosteroid Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroid Medication as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Corticosteroid Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Corticosteroid Medication Sales by Region (2018-2023) & (K Units)
Table 18. Global Corticosteroid Medication Sales Market Share by Region (2018-2023)
Table 19. Global Corticosteroid Medication Sales by Region (2024-2029) & (K Units)
Table 20. Global Corticosteroid Medication Sales Market Share by Region (2024-2029)
Table 21. Global Corticosteroid Medication Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Corticosteroid Medication Revenue Market Share by Region (2018-2023)
Table 23. Global Corticosteroid Medication Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Corticosteroid Medication Revenue Market Share by Region (2024-2029)
Table 25. North America Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 27. North America Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 28. North America Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 32. Europe Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 33. Europe Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Corticosteroid Medication Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Corticosteroid Medication Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Corticosteroid Medication Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Corticosteroid Medication Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Corticosteroid Medication Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Corticosteroid Medication Sales (K Units) by Type (2018-2023)
Table 51. Global Corticosteroid Medication Sales (K Units) by Type (2024-2029)
Table 52. Global Corticosteroid Medication Sales Market Share by Type (2018-2023)
Table 53. Global Corticosteroid Medication Sales Market Share by Type (2024-2029)
Table 54. Global Corticosteroid Medication Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Corticosteroid Medication Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Corticosteroid Medication Revenue Market Share by Type (2018-2023)
Table 57. Global Corticosteroid Medication Revenue Market Share by Type (2024-2029)
Table 58. Global Corticosteroid Medication Price (US$/Unit) by Type (2018-2023)
Table 59. Global Corticosteroid Medication Price (US$/Unit) by Type (2024-2029)
Table 60. Global Corticosteroid Medication Sales (K Units) by Application (2018-2023)
Table 61. Global Corticosteroid Medication Sales (K Units) by Application (2024-2029)
Table 62. Global Corticosteroid Medication Sales Market Share by Application (2018-2023)
Table 63. Global Corticosteroid Medication Sales Market Share by Application (2024-2029)
Table 64. Global Corticosteroid Medication Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Corticosteroid Medication Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Corticosteroid Medication Revenue Market Share by Application (2018-2023)
Table 67. Global Corticosteroid Medication Revenue Market Share by Application (2024-2029)
Table 68. Global Corticosteroid Medication Price (US$/Unit) by Application (2018-2023)
Table 69. Global Corticosteroid Medication Price (US$/Unit) by Application (2024-2029)
Table 70. Sumitomo Corporation Information
Table 71. Sumitomo Description and Business Overview
Table 72. Sumitomo Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sumitomo Corticosteroid Medication Product
Table 74. Sumitomo Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer Corticosteroid Medication Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Corticosteroid Medication Product
Table 84. Novartis Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Merck Corticosteroid Medication Product
Table 89. Merck Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Corticosteroid Medication Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson Corticosteroid Medication Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. GSK Corporation Information
Table 101. GSK Description and Business Overview
Table 102. GSK Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. GSK Corticosteroid Medication Product
Table 104. GSK Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca Corticosteroid Medication Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cipla Corticosteroid Medication Product
Table 114. Cipla Recent Developments/Updates
Table 115. LEO Pharma Corporation Information
Table 116. LEO Pharma Description and Business Overview
Table 117. LEO Pharma Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. LEO Pharma Corticosteroid Medication Product
Table 119. LEO Pharma Recent Developments/Updates
Table 120. Abbott Laboratories Corporation Information
Table 121. Abbott Laboratories Description and Business Overview
Table 122. Abbott Laboratories Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Abbott Laboratories Corticosteroid Medication Product
Table 124. Abbott Laboratories Recent Developments/Updates
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Bayer Corticosteroid Medication Product
Table 129. Bayer Recent Developments/Updates
Table 130. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information
Table 131. Tianjin Tianyao Pharmaceuticals Co., Ltd. Description and Business Overview
Table 132. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product
Table 134. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 135. Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
Table 136. Zhejiang Xianju Pharmaceutical Co.,Ltd Description and Business Overview
Table 137. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product
Table 139. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 140. Shandong Xinhua Pharmaceutical Company Limited Corporation Information
Table 141. Shandong Xinhua Pharmaceutical Company Limited Description and Business Overview
Table 142. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product
Table 144. Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
Table 145. Yangzi River Pharmaceutical Group Corporation Information
Table 146. Yangzi River Pharmaceutical Group Description and Business Overview
Table 147. Yangzi River Pharmaceutical Group Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Yangzi River Pharmaceutical Group Corticosteroid Medication Product
Table 149. Yangzi River Pharmaceutical Group Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Corticosteroid Medication Distributors List
Table 153. Corticosteroid Medication Customers List
Table 154. Corticosteroid Medication Market Trends
Table 155. Corticosteroid Medication Market Drivers
Table 156. Corticosteroid Medication Market Challenges
Table 157. Corticosteroid Medication Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 1. Global Corticosteroid Medication Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Corticosteroid Medication Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Corticosteroid Medication Market Competitive Situation by Manufacturers in 2022
Table 4. Global Corticosteroid Medication Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Corticosteroid Medication Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Corticosteroid Medication Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Corticosteroid Medication Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Corticosteroid Medication Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Corticosteroid Medication, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Corticosteroid Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Corticosteroid Medication, Product Type & Application
Table 12. Global Key Manufacturers of Corticosteroid Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Corticosteroid Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroid Medication as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Corticosteroid Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Corticosteroid Medication Sales by Region (2018-2023) & (K Units)
Table 18. Global Corticosteroid Medication Sales Market Share by Region (2018-2023)
Table 19. Global Corticosteroid Medication Sales by Region (2024-2029) & (K Units)
Table 20. Global Corticosteroid Medication Sales Market Share by Region (2024-2029)
Table 21. Global Corticosteroid Medication Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Corticosteroid Medication Revenue Market Share by Region (2018-2023)
Table 23. Global Corticosteroid Medication Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Corticosteroid Medication Revenue Market Share by Region (2024-2029)
Table 25. North America Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 27. North America Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 28. North America Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 32. Europe Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 33. Europe Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Corticosteroid Medication Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Corticosteroid Medication Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Corticosteroid Medication Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Corticosteroid Medication Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Corticosteroid Medication Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Corticosteroid Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Corticosteroid Medication Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Corticosteroid Medication Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Corticosteroid Medication Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Corticosteroid Medication Sales (K Units) by Type (2018-2023)
Table 51. Global Corticosteroid Medication Sales (K Units) by Type (2024-2029)
Table 52. Global Corticosteroid Medication Sales Market Share by Type (2018-2023)
Table 53. Global Corticosteroid Medication Sales Market Share by Type (2024-2029)
Table 54. Global Corticosteroid Medication Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Corticosteroid Medication Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Corticosteroid Medication Revenue Market Share by Type (2018-2023)
Table 57. Global Corticosteroid Medication Revenue Market Share by Type (2024-2029)
Table 58. Global Corticosteroid Medication Price (US$/Unit) by Type (2018-2023)
Table 59. Global Corticosteroid Medication Price (US$/Unit) by Type (2024-2029)
Table 60. Global Corticosteroid Medication Sales (K Units) by Application (2018-2023)
Table 61. Global Corticosteroid Medication Sales (K Units) by Application (2024-2029)
Table 62. Global Corticosteroid Medication Sales Market Share by Application (2018-2023)
Table 63. Global Corticosteroid Medication Sales Market Share by Application (2024-2029)
Table 64. Global Corticosteroid Medication Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Corticosteroid Medication Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Corticosteroid Medication Revenue Market Share by Application (2018-2023)
Table 67. Global Corticosteroid Medication Revenue Market Share by Application (2024-2029)
Table 68. Global Corticosteroid Medication Price (US$/Unit) by Application (2018-2023)
Table 69. Global Corticosteroid Medication Price (US$/Unit) by Application (2024-2029)
Table 70. Sumitomo Corporation Information
Table 71. Sumitomo Description and Business Overview
Table 72. Sumitomo Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sumitomo Corticosteroid Medication Product
Table 74. Sumitomo Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer Corticosteroid Medication Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Corticosteroid Medication Product
Table 84. Novartis Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Merck Corticosteroid Medication Product
Table 89. Merck Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Corticosteroid Medication Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson Corticosteroid Medication Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. GSK Corporation Information
Table 101. GSK Description and Business Overview
Table 102. GSK Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. GSK Corticosteroid Medication Product
Table 104. GSK Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca Corticosteroid Medication Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cipla Corticosteroid Medication Product
Table 114. Cipla Recent Developments/Updates
Table 115. LEO Pharma Corporation Information
Table 116. LEO Pharma Description and Business Overview
Table 117. LEO Pharma Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. LEO Pharma Corticosteroid Medication Product
Table 119. LEO Pharma Recent Developments/Updates
Table 120. Abbott Laboratories Corporation Information
Table 121. Abbott Laboratories Description and Business Overview
Table 122. Abbott Laboratories Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Abbott Laboratories Corticosteroid Medication Product
Table 124. Abbott Laboratories Recent Developments/Updates
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Bayer Corticosteroid Medication Product
Table 129. Bayer Recent Developments/Updates
Table 130. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information
Table 131. Tianjin Tianyao Pharmaceuticals Co., Ltd. Description and Business Overview
Table 132. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product
Table 134. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 135. Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
Table 136. Zhejiang Xianju Pharmaceutical Co.,Ltd Description and Business Overview
Table 137. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product
Table 139. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 140. Shandong Xinhua Pharmaceutical Company Limited Corporation Information
Table 141. Shandong Xinhua Pharmaceutical Company Limited Description and Business Overview
Table 142. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product
Table 144. Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
Table 145. Yangzi River Pharmaceutical Group Corporation Information
Table 146. Yangzi River Pharmaceutical Group Description and Business Overview
Table 147. Yangzi River Pharmaceutical Group Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Yangzi River Pharmaceutical Group Corticosteroid Medication Product
Table 149. Yangzi River Pharmaceutical Group Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Corticosteroid Medication Distributors List
Table 153. Corticosteroid Medication Customers List
Table 154. Corticosteroid Medication Market Trends
Table 155. Corticosteroid Medication Market Drivers
Table 156. Corticosteroid Medication Market Challenges
Table 157. Corticosteroid Medication Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Corticosteroid Medication
Figure 2. Global Corticosteroid Medication Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Corticosteroid Medication Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Eye Drops Product Picture
Figure 7. Lotions, Creams, Ointments, or Gels Product Picture
Figure 8. Nasal or Mouth Sprays Product Picture
Figure 9. Injections Product Picture
Figure 10. Global Corticosteroid Medication Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Corticosteroid Medication Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Pharmacy
Figure 15. Global Corticosteroid Medication Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Corticosteroid Medication Market Size (2018-2029) & (US$ Million)
Figure 17. Global Corticosteroid Medication Sales (2018-2029) & (K Units)
Figure 18. Global Corticosteroid Medication Average Price (US$/Unit) & (2018-2029)
Figure 19. Corticosteroid Medication Report Years Considered
Figure 20. Corticosteroid Medication Sales Share by Manufacturers in 2022
Figure 21. Global Corticosteroid Medication Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Corticosteroid Medication Players: Market Share by Revenue in 2022
Figure 23. Corticosteroid Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Corticosteroid Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 26. North America Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 27. United States Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 30. Europe Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 31. Germany Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Corticosteroid Medication Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Corticosteroid Medication Revenue Market Share by Region (2018-2029)
Figure 38. China Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 46. Latin America Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Colombia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Corticosteroid Medication by Type (2018-2029)
Figure 57. Global Revenue Market Share of Corticosteroid Medication by Type (2018-2029)
Figure 58. Global Corticosteroid Medication Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Corticosteroid Medication by Application (2018-2029)
Figure 60. Global Revenue Market Share of Corticosteroid Medication by Application (2018-2029)
Figure 61. Global Corticosteroid Medication Price (US$/Unit) by Application (2018-2029)
Figure 62. Corticosteroid Medication Value Chain
Figure 63. Corticosteroid Medication Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Product Picture of Corticosteroid Medication
Figure 2. Global Corticosteroid Medication Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Corticosteroid Medication Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Eye Drops Product Picture
Figure 7. Lotions, Creams, Ointments, or Gels Product Picture
Figure 8. Nasal or Mouth Sprays Product Picture
Figure 9. Injections Product Picture
Figure 10. Global Corticosteroid Medication Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Corticosteroid Medication Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Pharmacy
Figure 15. Global Corticosteroid Medication Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Corticosteroid Medication Market Size (2018-2029) & (US$ Million)
Figure 17. Global Corticosteroid Medication Sales (2018-2029) & (K Units)
Figure 18. Global Corticosteroid Medication Average Price (US$/Unit) & (2018-2029)
Figure 19. Corticosteroid Medication Report Years Considered
Figure 20. Corticosteroid Medication Sales Share by Manufacturers in 2022
Figure 21. Global Corticosteroid Medication Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Corticosteroid Medication Players: Market Share by Revenue in 2022
Figure 23. Corticosteroid Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Corticosteroid Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 26. North America Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 27. United States Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 30. Europe Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 31. Germany Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Corticosteroid Medication Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Corticosteroid Medication Revenue Market Share by Region (2018-2029)
Figure 38. China Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 46. Latin America Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Colombia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Corticosteroid Medication Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Corticosteroid Medication Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Corticosteroid Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Corticosteroid Medication by Type (2018-2029)
Figure 57. Global Revenue Market Share of Corticosteroid Medication by Type (2018-2029)
Figure 58. Global Corticosteroid Medication Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Corticosteroid Medication by Application (2018-2029)
Figure 60. Global Revenue Market Share of Corticosteroid Medication by Application (2018-2029)
Figure 61. Global Corticosteroid Medication Price (US$/Unit) by Application (2018-2029)
Figure 62. Corticosteroid Medication Value Chain
Figure 63. Corticosteroid Medication Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
